Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease

Epstein-Barr virus (EBV) is a human herpes virus that infects over 90% of the world’s population and is linked to development of cancer. In immune-competent individuals, EBV infection is mitigated by a highly efficient virus-specific memory T-cell response. Risk of EBV-driven cancers increases with...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Vaccines (Basel)
Glavni autori: Ahmed, Elshafa Hassan, Brooks, Eric, Sloan, Shelby, Schlotter, Sarah, Jeney, Frankie, Hale, Claire, Mao, Charlene, Zhang, Xiaoli, McLaughlin, Eric, Shindiapina, Polina, Shire, Salma, Das, Manjusri, Prouty, Alexander, Lozanski, Gerard, Mamuye, Admasu T., Abebe, Tamrat, Alinari, Lapo, Caligiuri, Michael A., Baiocchi, Robert A.
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8228306/
https://ncbi.nlm.nih.gov/pubmed/34073261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9060555
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items